Exact Mass: 999.3954040000001
Exact Mass Matches: 999.3954040000001
Found 39 metabolites which its exact mass value is equals to given mass value 999.3954040000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lacto-N-difucopentaose II
Lacto-N-difucopentaose II is an oligosaccharide first isolated from human milk by recycling chromatography in 1988. Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. (PMID 3274083, 10837303, 11787695, 14530096, 17002410) [HMDB] Lacto-N-difucopentaose II is an oligosaccharide first isolated from human milk by recycling chromatography in 1988. Is resistant to enzymic hydrolysis in the gastrointestinal tract of the infant; it is postulated that they reach the large intestine where they serve as substrates for bacterial metabolism. Oligosaccharides in human milk represent a group of bioactive molecules that have evolved to be an abundant and diverse component of human milk, even though they have no direct nutritive value to the infant. (PMID 3274083, 10837303, 11787695, 14530096, 17002410).
Lacto-N-difucohexaose
Lacto-N-difucohexaose (LDFH) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. Calicivirus diarrhea occurs less often in infants whose mothers milk contains high levels of LDFH. (PMID: 15343178, 17375110, 12568665) [HMDB] Lacto-N-difucohexaose (LDFH) is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. Calicivirus diarrhea occurs less often in infants whose mothers milk contains high levels of LDFH. (PMID: 15343178, 17375110, 12568665).
beta-D-Galp(1->3)-[alpha-L-Fucp(1->4)]-beta-D-GlcpNAc(1->3)-beta-D-Galp(1->4)-[alpha-L-Fuc(1->3)]-D-Glcp|lacto-N-difucohexaose II
LNDFH II
LND I
ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC
(Z)-5-[3-[5-[3-[[(E)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-8-[3-[[(Z)-4-carboxy-3-methylbut-2-enoyl]-hydroxyamino]propyl]-11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl-hydroxyamino]-3-methyl-5-oxopent-3-enoic acid
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)b-Glc
alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Gal(a1-3)[Fuc(a1-4)]GlcNAc(b1-4)[Fuc(a1-3)]Gal(b1-4)Glc
Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)b-Glc
Fuc(a1-2)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)a-Man
Fuc(a1-4)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Glc
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-4)Gal(b1-4)Glc
Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]Glc
Fuc(a1-2)Gal(b1-3)GlcNAc(b1-3)[Fuc(a1-2)]Gal(b1-4)Glc
Fuc(a1-2)[Gal(a1-3)]Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal
Fuc(a1-2)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)Man
(3s,6r,8r)-15-[(4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,14-trihydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-(1h-indol-3-yl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
C53H61NO18 (999.3888446000001)
(3e)-4-{[3-(17-{3-[(2e)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-14-{3-[(2z)-4-carboxy-n-hydroxy-3-methylbut-2-enamido]propyl}-3,6,9,12,15,18-hexahydroxy-5,8-bis(hydroxymethyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl)propyl](hydroxy)carbamoyl}-3-methylbut-3-enoic acid
(3s,6r,8r)-15-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,12-trihydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-(1h-indol-3-yl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1,9,11,13(21),15,17-hexaene-4,14,19-trione
C53H61NO18 (999.3888446000001)
3-[(5-{[4-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl)oxy]-6,8,12,14-tetrahydroxy-18-(indol-3-ylidene)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,12,14,16-hexaene-4,19-dione
C53H61NO18 (999.3888446000001)
(3s,6r,8r)-15-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,12,14-tetrahydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-[(3z)-indol-3-ylidene]-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,12,14,16-hexaene-4,19-dione
C53H61NO18 (999.3888446000001)
(3s,6r,8r)-3-{[(2s,5s,6s)-5-{[(2s,4r,5r,6r)-4-{[(2r,5r,6r)-5-{[(2r,4s,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6,8,12,14-tetrahydroxy-18-(indol-3-ylidene)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,12,14,16-hexaene-4,19-dione
C53H61NO18 (999.3888446000001)
(3s,6r,8r)-15-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-6,8,14-trihydroxy-3-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-(1h-indol-3-yl)-6-methyl-20-oxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁷,²¹]henicosa-1(21),2(11),9,13,15,17-hexaene-4,12,19-trione
C53H61NO18 (999.3888446000001)